ACPE Activity Number: 0204-0000-21-413-H01-P
Activity Date: May 25, 2021
Expiration Date: May 25, 2022
Activity Type: Application-based
CE Credits: 1.0 hour
Activity Fee: Free of charge
This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity was planned to meet the educational needs of pharmacists who practice in hospitals and health systems.
Given the risk of severe COVID-19 complications for people with diabetes, optimal glucose management is likely to affect patient outcomes. With the temporary approval by FDA of the use of non-invasive remote monitoring devices in hospitals, healthcare professionals will need education on appropriate use in this care setting. This educational activity will identify which hospitalized patients are suitable candidates for continuous glucose monitoring (CGM). Workflow and policies and procedures that facilitate their safe use will also be explained. The activity will conclude with a discussion of the role the pharmacist in helping patients optimize use of CGM devices in the hospital setting.
At the conclusion of this activity, participants should be able to:
- Identify which hospitalized patients with diabetes and COVID-19 infections are candidates for CGM systems.
- Discuss the benefits of the use of CGMs in hospitals during the COVID-19 pandemic on healthcare personnel and patients.
- Summarize the role of the pharmacist in employing continuous glucose monitoring systems in appropriate hospitalized patients.
Matt Baker, Pharm.D., M.S., BCPS, BPLA, Activity Chair
Pharmacy Clinical Supervisor
Pharmacy Residency Program Director
North Kansas City Hospital
North Kansas City, Missouri
Guillermo E. Umpierrez, M.D., CDCES, MACP, FACE
Professor of Medicine, Emory University School of Medicine
Division of Endocrinology and Metabolism
Chief of Diabetes and Endocrinology, Grady Health Systems
Relevant Financial Relationship Disclosure
The following persons in control of this activity’s content have one or more relevant financial relationships.
- Guillermo Umpierrez: Investigator - Novo Nordisk, Dexcom, Astra Zeneca
All of the relevant financial relationships for the aforementioned individuals have been mitigated.
All others in control of the content of this activity do not have a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence definition of ineligible company.
Methods and CE Requirements
This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.
System Technical Requirements
Courses and learning activities are delivered via your Web browser and Acrobat PDF. Users should have a basic comfort level using a computer and navigating web sites.
View the minimum technical and system requirements for learning activities.
Provided by ASHP
Supported by an educational grant from Dexcom.